Miguel Ángel Sanz Alonso-rekin lankidetzan egindako argitalpenak (9)

2015

  1. Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: Phase Ib/II panobidara study

    Haematologica, Vol. 100, Núm. 10, pp. 1294-1300

2014

  1. Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients

    Annals of Hematology, Vol. 93, Núm. 2, pp. 299-307

2011

  1. Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

    Haematologica, Vol. 96, Núm. 10, pp. 1470-1477

  2. Update on bacteraemia in oncology and hematology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 48-53

2009

  1. Imipenem/Cilastatin with or without Glycopeptide as Initial Antibiotic Therapy for Recipients of Autologous Stem Cell Transplantation: Results of a Spanish Multicenter Study

    Biology of Blood and Marrow Transplantation, Vol. 15, Núm. 4, pp. 512-516

2008

  1. Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71

2002

  1. Cefepime plus amikacin versus pipercillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: Results of an open, randomized, multicentre trial

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. 1, pp. 79-88

2000

  1. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: The Spanish experience

    Haematologica, Vol. 85, Núm. 5, pp. 530-538

1999

  1. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry

    Bone Marrow Transplantation, Vol. 24, Núm. 7, pp. 723-728